Syntheses and biological evaluation of new glyco-modified angucyclin-antibiotics

Citation
A. Kirschning et al., Syntheses and biological evaluation of new glyco-modified angucyclin-antibiotics, BIO MED CH, 8(9), 2000, pp. 2347-2354
Citations number
49
Categorie Soggetti
Chemistry & Analysis
Journal title
BIOORGANIC & MEDICINAL CHEMISTRY
ISSN journal
09680896 → ACNP
Volume
8
Issue
9
Year of publication
2000
Pages
2347 - 2354
Database
ISI
SICI code
0968-0896(200009)8:9<2347:SABEON>2.0.ZU;2-L
Abstract
The synthesis of novel aquayamycin-derived angucycline antibiotics 13a d ha s been achieved. Glycosylation of aquayamycin (6) using 2-selenoglycosyl ac etate 7 as glycosyl donor proceeded in excellent yield but attempts to redu ctively remove the selenyl group led to rearrangement or further aromatizat ion of the aglycon. As a consequence of these results, it became possible t o prepare urdamycinone B (10) starting from aquayamycin (6). Tn addition, s ilyl protected D-olivals 12a,b were attached to the C-glycoside domain of a quayamycin (6) under protic conditions. As expected, the hydroxy and phenol groups of the benz[a]anthracene framework of 6 did not react under the gly cosylation conditions employed. Stepwise removal of the silyl protecting gr oup starting with tetrabutyl ammonium fluoride followed by use of the HF/py ridine complex suppressed a possible rearrangement of the aglycon and succe ssfully terminated the sequence. The new angucycline-antibiotics 13a and 13 b are some of the most potent xanthine oxidase inhibitors known and show cy totoxic activity with ED50-values in the range of 12.6-2.9 x 10(-6) M (C) 2 000 Elsevier Science Ltd. All rights reserved.